MedTrace Logo

A Post Marketing Surveillance Study

NCT03366779 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-03-15

No results posted yet for this study

Summary

This study is a prospective, multi-center study to monitor the early safety and performance of one iteration of the Barricaid Anular Closure Device (ACD) - 6mm anchor width, when used as an adjunct to limited discectomy.

Conditions

  • Lumbar Disc Herniation
  • Annular Disc Tear
  • Annular Tear of Lumbar Disc

Interventions

DEVICE

6mm annular closure device

6MM Barricaid annular closure device implantation following standard lumbar discectomy

Sponsors & Collaborators

  • Intrinsic Therapeutics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-16
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Belgium
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03366779 on ClinicalTrials.gov